A recent poll shows that most Americans say the country’s health care system is handled poorly, and even more are frustrated by the cost of prescription drugs.
In a study reported this week in JAMA Network Open, researchers found no association between a drug’s list price and research and development costs. The study looked at 60 drugs approved by the Food and Drug Administration between 2009 and 2018.
Biogen stock is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the company's new Alzheimer's drug in partnership with Japan's Eisai.
Pfizer and BioNTech completed their submission to the FDA for emergency use authorization of their updated COVID-19 booster for children ages 5 through 11.
The concentrated effort to develop, manufacture and distribute vaccines as the Covid-19 pandemic began to rage across the world highlighted the importance of the supply chain and helped set a model for how lifesaving medicines will be rolled out in the future, a Pfizer Inc. executive said.
